Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/75841
Campo DC Valoridioma
dc.contributor.authorMedina, Alfonsoen_US
dc.contributor.authorPan, Manuelen_US
dc.contributor.authorSuärez De Lezo, Joséen_US
dc.contributor.authorRomero, Miguelen_US
dc.contributor.authorHernández, Enriqueen_US
dc.contributor.authorSegura, Joséen_US
dc.contributor.authorMelián, Franciscoen_US
dc.contributor.authorOrtega, Joséen_US
dc.contributor.authorMorales, Juanen_US
dc.contributor.authorWangüemert, Fernandoen_US
dc.contributor.authorBenítez, Fernandoen_US
dc.contributor.authorAlonso, Silviaen_US
dc.contributor.authorBenítez, Jacintoen_US
dc.contributor.authorJaramuillo, Nicolásen_US
dc.contributor.authorDios, Franciscoen_US
dc.date.accessioned2020-11-23T15:04:33Z-
dc.date.available2020-11-23T15:04:33Z-
dc.date.issued1997en_US
dc.identifier.issn0300-8932en_US
dc.identifier.otherScopus-
dc.identifier.urihttp://hdl.handle.net/10553/75841-
dc.description.abstractIntroduction. Although direct balloon angioplasty has emerged as an alternative to thrombolytic therapy in patients with acute myocardial infarction, reocclusion and restenosis rates are limiting factors. We postulated that these limitations could be partly overcome by primary stenting of the responsible lesion. Material and methods. Since January/94 we have studied 59 patients with acute myocardial infarction who were treated in the early phase (3.1 ±2 hours since the onset of symptoms) by elective Palmaz-Schatz stent implantation. No adjunctive thrombolytic therapy was associated. Two patients were in cardiogenic shock and were treated under percutaneous cardiopulmonary support. At cardiac catheterization a left ventriculography and coronary angiograms were obtained. Then, mechanical recanalization of the responsible lesion was performed. If the angiographic anatomy was considered suitable, a stent was implanted at the lesion. Results. The infarct related artery was the left anterior descending in 29 patients, the circunflex in 14 and the right coronary artery in 16. At baseline conditions, 40 patients had a totally occluded artery and 19 showed a TIMI-grande 1 antegrade flow. One patient had an early clinical recurrence 4 days later, which required an additional divided Palmaz-Schatz stent at the distal portion of the lesion, in order to seal a residual dissection. All remaining patients had a favourable clinical course without major complications. Immediately after treatment the minimal lumen diameter was 3.2 ± 0.4 mm and no residual stenosis was detectable at the treated segment. Six-month angiographie reevaluation was performed in all 29 (49%) eligible patients. Restenosis (> 50% stenosis) was detected in 6 out of the 29 evaluated patients (21%). Conclusions. Primary stent implantation in selected patients with an evolving myocardial infarction provides good initial and 6-month results.en_US
dc.languagespaen_US
dc.relation.ispartofRevista Espanola de Cardiologiaen_US
dc.sourceRevista Espanola de Cardiologia [ISSN 0300-8932], v. 50 (SUPPL. 2), p. 63-68, (Diciembre 1997)en_US
dc.subject320501 Cardiologíaen_US
dc.subject320704 Patología cardiovascularen_US
dc.subject321307 Cirugía del corazónen_US
dc.subject.otherAcute Myocardial Infarctionen_US
dc.subject.otherStenten_US
dc.titlePrimary stent treatment for acute evolving myocardial infarction Tratamiento primario con stent en la fase aguda del infarto de miocardioen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.scopus0030628183-
dc.contributor.authorscopusid7202723590-
dc.contributor.authorscopusid7202544866-
dc.contributor.authorscopusid55822963798-
dc.contributor.authorscopusid7202430759-
dc.contributor.authorscopusid7402296666-
dc.contributor.authorscopusid55415591100-
dc.contributor.authorscopusid7003549899-
dc.contributor.authorscopusid7402624018-
dc.contributor.authorscopusid56779448100-
dc.contributor.authorscopusid6602241581-
dc.contributor.authorscopusid7005560445-
dc.contributor.authorscopusid57196933068-
dc.contributor.authorscopusid57214523847-
dc.contributor.authorscopusid6503860635-
dc.contributor.authorscopusid6602196394-
dc.description.lastpage68en_US
dc.identifier.issueSUPPL. 2-
dc.description.firstpage63en_US
dc.relation.volume50en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages6en_US
dc.utils.revisionen_US
dc.date.coverdateDiciembre 1997en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sellofecytSello FECYT
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

8
actualizado el 24-mar-2024

Visitas

72
actualizado el 18-feb-2024

Google ScholarTM

Verifica


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.